Bayer shares up 3.5% after U.S. government's backing in glyphosate lawsuit

This post was originally published on this site

FRANKFURT (Reuters) – Bayer (DE:) shares rose as much as 3.5% on Monday, reaching their highest level in 14 months, after the United States government said that a $25 million glyphosate decision against the company should be reversed.

The U.S. Environmental Protection Agency and the Justice Department on Friday said in a friend of the court brief a federal appeals court should reverse a lower court verdict finding the company liable in the case of a man who blamed the weed killer by Bayer’s U.S. unit Monsanto (NYSE:) for his cancer.

Bayer denies its Roundup weed killer causes cancer.

Shares in the company, which faces multiple U.S. lawsuits that could result in overall compensation payments worth billions of dollars, rose to 74.00 euros at the Frankfurt stock exchange.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Add Comment